Gene/Protein Disease Symptom Drug Enzyme Compound
Pivot Concepts:   Target Concepts:
Query: UMLS:C0000737 (abdominal pain)
 31,184 document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)

Primary dysmenorrhea is a common gynaecological symptom complex characterized by a painful syndrome occurring predominantly on the first and the second day of the cycle and associated with concomitant autonomic phenomena. In a randomized double-blind study, the therapeutic effect of magnesium has been investigated in 32 women (16 to 42 years old) who have been treated in the gynaecological outpatient-department at our clinic because of primary dysmenorrhea. The dosage of Magnesiocard comprised 3 X 5 mmol granulate orally on the day preceding menstruation and on the first and the second day of the cycle. At the end of the study, which covered six cycles, we were able to analyze the results in 21 patients, 11 having been treated with magnesium and 10 with placebo. While in the magnesium group only a slight effect was noted on the first day of the cycle under therapy when compared to both the placebo group and the dysmenorrhea disturbances persisting before therapy was started, magnesium had a therapeutic effect on both back pain and lower abdominal pain on the second and the third day of the cycle. Parallel to this therapeutic influence on the symptomatology of dysmenorrhea, a marked reduction in absences from work due to the dysmenorrhea was also noted. The possibilities of magnesium therapy in dysmenorrhea should be investigated further in multicentre studies.
 ...
PMID:[Therapeutic effects of magnesium in dysmenorrhea]. 234 10

Dysmenorrhea means not only uterine pain in the lower abdomen and back, but in many cases headaches, depression, perspiration, nausea, vomiting, and diarrhea, mostly during the first 12-48 hours of menstruation. Primary dysmenorrhea begins at a young age, and some investigators have stated that 50% all of women suffer from dysmenorrhea. No gynecological cure has been found. The socioeconomic consequences are substantial due to absences from school and work. It was previously believed that dysmenorrhea was caused by hormonal imbalance, but there is now evidence that it could be caused by prostaglandins in the menstrual blood. When prostaglandins are administered, the aforementioned side effects of dysmenorrhea are experienced. Since the 1960s, oral contraceptives (OCs) have been administered with success. If for some reason OCs are not advisable, there are very few effective alternatives. Dydrogesterone, a retroprogesterone derivative, does not slow down ovulation, but has to be taken for several weeks of the month just like the pill. Several inhibitors of prostaglandin synthesis are available, but naproxene is the best. It is the longest acting, requiring administration only 2 times/day. It works immediately and can be taken when needed. Because it is used only when needed, there is a minimm of side effects from long-term use. It should not be used by women under 16 years of age. Side effects of all prostaglandin synthesis inhibitors are nausea, vomiting, abdominal pain, and diarrhea. The use of calcium is also advised and warrants further study.
 ...
PMID:[Primary dysmenorrhea: current insights in etiology and treatment]. 642 13

Primary dysmenorrhea (PDM) is the most prevalent gynecological disorder for women in the reproductive age. PDM patients suffer from lower abdominal pain that starts with the onset of the menstrual flow. Prolonged nociceptive input to the central nervous system can induce functional and structural alterations throughout the nervous system. In PDM, a chronic viscero-nociceptive drive of cyclic nature, indications of central sensitization and altered brain metabolism suggest a substantial central reorganization. Previously, we hypothesized that disinhibition of orbitofrontal networks could be responsible for increased pain and negative affect in PDM. Here, we further tested this hypothesis. We used an optimized voxel-based morphometry (VBM) approach to compare total and regional gray matter (GM) increases and decreases in 32 PDM patients with 32 healthy age and menstrual cycle matched (peri-ovulatory phase) controls. Abnormal decreases were found in regions involved in pain transmission, higher level sensory processing, and affected regulation while increases were found in regions involved in pain modulation and in regulation of endocrine function. Moreover, GM changes in regions involved in top-down pain modulation and in generation of negative affect were related to the severity of the experienced PDM pain. Our results demonstrate that abnormal GM volume changes are present in PDM patients even in the absence of pain. These changes may underpin a combination of impaired pain inhibition, increased pain facilitation and increased affect. Our findings highlight that longer lasting central changes may occur not only in sustained chronic pain conditions but also in cyclic occurring pain conditions.
 ...
PMID:Brain morphological changes associated with cyclic menstrual pain. 2070 14

Dysmenorrhea is defined as symptoms associated with menstruation, such as abdominal pain, cramping and lumbago, that interfere with daily activity. Primary dysmenorrhea refers to menstrual pain without underlying pathology, whereas secondary dysmenorrhea is menstrual pain associated with underlying pathology. Endometriosis, one of the main causes of secondary dysmenorrhea, induces dysmenorrhea, pelvic pain and infertility, resulting in marked reduction of quality of life during reproductive age. This review article is a comprehensive overview of dysmenorrhea and endometriosis in young women.
...
PMID:Dysmenorrhea and endometriosis in young women. 2457 76